NursingCali AG Providers on Data Privacy, Anti-Implicit Bias Training
Stakeholders are urged to take proactive steps to protect patient data, provide perinatal staff with anti-implicit bias training.
Covid-19Pfizer CEO to Public: Just Trust Us on the COVID Booster
Pfizer has not yet delivered conclusive proof to back up that confidence.
StrategyNational Academies' Report Took Pharma-Friendly Stance After Millions in Gifts From Drugmakers
A KHN review of treasurer reports from 2015 through 2020 shows that pharmaceutical companies have given consistently to the national...
StrategyStates Move Ahead With Canada Drug Importation While Awaiting Signal From Biden
The Pharmaceutical Research and Manufacturers of America, an industry trade group, filed suit in federal court in Washington, D.C., to...
Clinical CareFewer Physicians Accepting Industry Payments, But Payment Values Stay Steady
A new study highlights the importance of tracking physician conflicts of interest.
StrategyDrug Lobby Rips Trump's 'Most Favored Nation' Mandate on Medicare Drug Prices
PhRMA says the White House has "doubled down on a reckless attack on the very companies working around the clock...
FinancePharmacists Call on N.Y. to Lift Restrictions to Fight Coronavirus
The Pharmacists Society of the State of New York released a six-point plan to address the outbreak.
FinanceRevenues Jumped 32% for CVS, Operating Income up to $12B
The company made a series of leadership changes in addition to releasing its earnings report.
FinanceAllergan Shareholders Approve $63B Abbvie Acquisition
The deal, first announced in June, received near-unanimous approval from the Dublin-based pharmaceutical company's shareholders.
FinanceCalifornia's New Transparency Law Reveals Steep Rise In Wholesale Drug Prices
Generic drugs saw the largest median increase of 37.6% from 2017 through the first quarter of 2019.
FinancePhRMA: Pelosi Bill Would Mean 'Lights Out' for Drug Startups
Drug lobby, feeling heat from Capitol Hill, ramps up its rhetoric.
FinanceLarge Chain Pharmacies Have Lowest Cash Prices for Generics, Less Variation
Consumers might be better off price shopping for generic prescription drugs, according to a new study.